High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities

Leukemia

Volumn 17, Issue 6, 2003, Pages 1091-1095

  Ishizawa, S ^a,b   Slovak, M L ^a   Popplewell, L ^a   Bedell, V ^a   Wrede, J E ^a   Carter, N H ^a   Snyder, D S ^a   Arber, D A ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b TOYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute lymphoblastic leukemia; Adult; Immunophenotyping; MLL; Therapy

Indexed keywords

ALKYLATING AGENT; ANTIGEN; BLEOMYCIN; CARBOPLATIN; CD15 ANTIGEN; CD65 ANTIGEN; CHLORMETHINE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; GYRASE INHIBITOR; IDARUBICIN; MITOXANTRONE; MIXED LINEAGE LEUKEMIA PROTEIN; PACLITAXEL; PREDNISONE; PROCARBAZINE; THIOTEPA; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CELL MATURATION; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 4; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; FREQUENCY ANALYSIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENETICS; IMMUNOPHENOTYPING; LATENT PERIOD; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; TIME;

EID: 0038040609     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402918     Document Type: Article

References (21)

1. Pui C-H, Behm FG, Raimondi SC, Dodge RK, George SL, Rivera GK et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 1989; 321: 136-142.
2. Bhatia S, Ramsay NKC, Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633-3639.
3. Pagano L, Pulsoni A, Tosti ME, Avvisati G, Mele L, Mele A et al. Clinical and biological features of acute myeloid leukaemia occurring as second malignancy: GIMEMA archive of adult acute leukaemia. Br J Haematol 2001; 112: 109-117.
4. Bhatia S, Louie AD, Bhatia R, O'Donnell MR, Fung H, Kashyap A et al. Solid cancers after bone marrow transplantation. J Clin Oncol 2001; 19: 464-471.
5. Rowley JD, Olney HJ. International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chromosomes Cancer 2002; 33: 331-345.
6. Traweek ST, Slovak ML, Nademanee AP, Brynes RK, Niland JC, Forman SJ. Clonal karyotypic hematopoietic-cell abnormalities occurring after autologous bone-marrow transplantation for Hodgkin's-disease and non-Hodgkin's-lymphoma. Blood 1994; 84: 957-963.
7. Pagano L, Pulsoni A, Tosti ME, Annino L, Mele A, Camera A et al. Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Br J Haematol 1999; 106: 1037-1040.
8. Andersen MK, Christiansen DH, Jensen BA, Ernst P, Hauge G, Pedersen-Bjergaard J. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992. Br J Haematol 2001; 114: 539-543.
9. Bloomfield CD, Archer KJ, Mrozek K, Lillington DM, Kaneko Y, Head DR et al. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002; 33: 362-378.
10. Khalidi HS, Chang KL, Medeiros LJ, Brynes RK, Slovak ML, Murata-Collins J et al. Acute lymphoblastic leukemia. Survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. Am J Clin Pathol 1999; 111: 467-476.
11. Arber DA, Jenkins KA. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. Am J Clin Pathol 1996; 106: 462-468.
12. ISCN (1995): In: Mitelman F (ed.), An International System for Human Cytogenetic Nomenclature. Basel: Karger, 1995.
13. Snyder DS, Rossi JJ, Wang J-J, Sniecinski IJ, Slovak ML, Wallace RB et al. Persistence of bcr-abl gene expession following bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Transplantation 1991; 51: 1033-1040.
14. Pedersen-Bjergaard J. Acute lymphoid leukemia with t(4;11) (q2l;q23) following chemotherapy with cytostatic agents targeting at DNA-topoisomerase II. Leukemia Res 1992; 16: 733-735.
15. Block AW, Carroll AJ, Hagemeijer A, Michaux L, van Lom K, Olney HJ et al. Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002; 33: 401-412.
16. Secker-Walker LM, Moorman AV, Bain BJ, Mehta AB. Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. Leukemia 1998; 12: 840-844.
17. Pui CH, Rubnitz JE, Hancock ML, Downing JR, Raimondi SC, Rivera GK et al. Reappraisal of the clinical and biologic significance of myeloid- associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol 1998; 16: 3768-3773.
18. Lenormand B, Bene MC, Lesesve JF, Bastard C, Tilly H, Lefranc MP et al. PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucemies. Leukemia Lymphoma 1998; 28: 329-342.
19. Ludwig WD, Rieder H, Bartram CR, Heinze B, Schwartz S, Gassmann W et al. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood 1998; 92: 1898-1909.
20. Borkhardt A, Wuchter C, Viehmann S, Pils S, Teigler-Schlegel A, Stanulla M et al. Infant acute lymphoblastic leukemia-combined cytogenetic, immunophenotypical and molecular analysis of 77 cases. Leukemia 2002; 16: 1685-1690.
21. Cimino G, Rapanotti MC, Biondi A, Elia L, LoCoco F, Price C et al. Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res 1997; 57: 2879-2883.